HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study

Elizabeth Hutchins, Ruibin Wang, Sina Rahmani, Rine Nakanishi, Sabina Haberlen, Lawrence Kingsley, Mallory D. Witt, Frank Joseph Palella, Lisa Paula Jacobson, Matthew J. Budoff, Wendy S Post

Research output: Contribution to journalArticle

Abstract

HIV infection has been associated with diastolic heart failure and atrial fibrillation. The purpose of this study is to determine whether HIV infection is associated with differences in left ventricular mass (LVM), left ventricular end-diastolic volume (LVEDV), and left atrial volume (LAV) indexed to body surface area (left ventricular mass index, left ventricular end-diastolic volume index [LVEDVI], and left atrial volume index [LAVI], respectively). Cross-sectional study of 721 men [425 HIV-infected (HIV+), 296 HIV-uninfected (HIV-) enrolled in the cardiovascular substudy of the Multicenter AIDS Cohort Study (MACS). Participants underwent cardiac computed tomography imaging. A blinded reader measured LVM, LVEDV, and LAV. We used multivariable linear regression models to evaluate whether LVEDVI, left ventricular mass index (LVMI), and LAVI differed by HIV serostatus, adjusting for demographics and cardiovascular disease risk factors. LVMI was significantly greater in HIV+ compared with HIV- men, with adjusted difference of 2.65 g/m2 (95% confidence interval 0.53-4.77, p < .001). Left ventricular end-diastolic index and LAVI did not differ significantly between the two groups. HIV-related factors (nadir CD4 count, clinical AIDS diagnosis, cumulative antiretroviral therapy use, and cumulative protease inhibitor use) were not significantly associated with LVMI, LVEDVI, or LAVI. LVM was significantly higher in HIV+ than HIV- men, which may contribute to the observed increased risk for diastolic heart failure associated with HIV infection. Although HIV infection has been associated with an increased risk for atrial fibrillation, we did not find any difference in LAV by HIV serostatus.

Original languageEnglish (US)
Pages (from-to)755-761
Number of pages7
JournalAIDS research and human retroviruses
Volume35
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

HIV Infections
Acquired Immunodeficiency Syndrome
Cohort Studies
HIV
Stroke Volume
Diastolic Heart Failure
Atrial Fibrillation
Linear Models
Body Surface Area
CD4 Lymphocyte Count
Protease Inhibitors
Cardiovascular Diseases
Cross-Sectional Studies
Tomography
Demography
Confidence Intervals

Keywords

  • AIDS
  • cardiomyopathy
  • diastolic
  • heart failure
  • HIV
  • X-ray computed tomography

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study. / Hutchins, Elizabeth; Wang, Ruibin; Rahmani, Sina; Nakanishi, Rine; Haberlen, Sabina; Kingsley, Lawrence; Witt, Mallory D.; Palella, Frank Joseph; Jacobson, Lisa Paula; Budoff, Matthew J.; Post, Wendy S.

In: AIDS research and human retroviruses, Vol. 35, No. 8, 01.08.2019, p. 755-761.

Research output: Contribution to journalArticle

Hutchins, Elizabeth ; Wang, Ruibin ; Rahmani, Sina ; Nakanishi, Rine ; Haberlen, Sabina ; Kingsley, Lawrence ; Witt, Mallory D. ; Palella, Frank Joseph ; Jacobson, Lisa Paula ; Budoff, Matthew J. ; Post, Wendy S. / HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study. In: AIDS research and human retroviruses. 2019 ; Vol. 35, No. 8. pp. 755-761.
@article{02e147d4ffc14579806eefba35ecb39b,
title = "HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study",
abstract = "HIV infection has been associated with diastolic heart failure and atrial fibrillation. The purpose of this study is to determine whether HIV infection is associated with differences in left ventricular mass (LVM), left ventricular end-diastolic volume (LVEDV), and left atrial volume (LAV) indexed to body surface area (left ventricular mass index, left ventricular end-diastolic volume index [LVEDVI], and left atrial volume index [LAVI], respectively). Cross-sectional study of 721 men [425 HIV-infected (HIV+), 296 HIV-uninfected (HIV-) enrolled in the cardiovascular substudy of the Multicenter AIDS Cohort Study (MACS). Participants underwent cardiac computed tomography imaging. A blinded reader measured LVM, LVEDV, and LAV. We used multivariable linear regression models to evaluate whether LVEDVI, left ventricular mass index (LVMI), and LAVI differed by HIV serostatus, adjusting for demographics and cardiovascular disease risk factors. LVMI was significantly greater in HIV+ compared with HIV- men, with adjusted difference of 2.65 g/m2 (95{\%} confidence interval 0.53-4.77, p < .001). Left ventricular end-diastolic index and LAVI did not differ significantly between the two groups. HIV-related factors (nadir CD4 count, clinical AIDS diagnosis, cumulative antiretroviral therapy use, and cumulative protease inhibitor use) were not significantly associated with LVMI, LVEDVI, or LAVI. LVM was significantly higher in HIV+ than HIV- men, which may contribute to the observed increased risk for diastolic heart failure associated with HIV infection. Although HIV infection has been associated with an increased risk for atrial fibrillation, we did not find any difference in LAV by HIV serostatus.",
keywords = "AIDS, cardiomyopathy, diastolic, heart failure, HIV, X-ray computed tomography",
author = "Elizabeth Hutchins and Ruibin Wang and Sina Rahmani and Rine Nakanishi and Sabina Haberlen and Lawrence Kingsley and Witt, {Mallory D.} and Palella, {Frank Joseph} and Jacobson, {Lisa Paula} and Budoff, {Matthew J.} and Post, {Wendy S}",
year = "2019",
month = "8",
day = "1",
doi = "10.1089/aid.2019.0014",
language = "English (US)",
volume = "35",
pages = "755--761",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - HIV Infection Is Associated with Greater Left Ventricular Mass in the Multicenter AIDS Cohort Study

AU - Hutchins, Elizabeth

AU - Wang, Ruibin

AU - Rahmani, Sina

AU - Nakanishi, Rine

AU - Haberlen, Sabina

AU - Kingsley, Lawrence

AU - Witt, Mallory D.

AU - Palella, Frank Joseph

AU - Jacobson, Lisa Paula

AU - Budoff, Matthew J.

AU - Post, Wendy S

PY - 2019/8/1

Y1 - 2019/8/1

N2 - HIV infection has been associated with diastolic heart failure and atrial fibrillation. The purpose of this study is to determine whether HIV infection is associated with differences in left ventricular mass (LVM), left ventricular end-diastolic volume (LVEDV), and left atrial volume (LAV) indexed to body surface area (left ventricular mass index, left ventricular end-diastolic volume index [LVEDVI], and left atrial volume index [LAVI], respectively). Cross-sectional study of 721 men [425 HIV-infected (HIV+), 296 HIV-uninfected (HIV-) enrolled in the cardiovascular substudy of the Multicenter AIDS Cohort Study (MACS). Participants underwent cardiac computed tomography imaging. A blinded reader measured LVM, LVEDV, and LAV. We used multivariable linear regression models to evaluate whether LVEDVI, left ventricular mass index (LVMI), and LAVI differed by HIV serostatus, adjusting for demographics and cardiovascular disease risk factors. LVMI was significantly greater in HIV+ compared with HIV- men, with adjusted difference of 2.65 g/m2 (95% confidence interval 0.53-4.77, p < .001). Left ventricular end-diastolic index and LAVI did not differ significantly between the two groups. HIV-related factors (nadir CD4 count, clinical AIDS diagnosis, cumulative antiretroviral therapy use, and cumulative protease inhibitor use) were not significantly associated with LVMI, LVEDVI, or LAVI. LVM was significantly higher in HIV+ than HIV- men, which may contribute to the observed increased risk for diastolic heart failure associated with HIV infection. Although HIV infection has been associated with an increased risk for atrial fibrillation, we did not find any difference in LAV by HIV serostatus.

AB - HIV infection has been associated with diastolic heart failure and atrial fibrillation. The purpose of this study is to determine whether HIV infection is associated with differences in left ventricular mass (LVM), left ventricular end-diastolic volume (LVEDV), and left atrial volume (LAV) indexed to body surface area (left ventricular mass index, left ventricular end-diastolic volume index [LVEDVI], and left atrial volume index [LAVI], respectively). Cross-sectional study of 721 men [425 HIV-infected (HIV+), 296 HIV-uninfected (HIV-) enrolled in the cardiovascular substudy of the Multicenter AIDS Cohort Study (MACS). Participants underwent cardiac computed tomography imaging. A blinded reader measured LVM, LVEDV, and LAV. We used multivariable linear regression models to evaluate whether LVEDVI, left ventricular mass index (LVMI), and LAVI differed by HIV serostatus, adjusting for demographics and cardiovascular disease risk factors. LVMI was significantly greater in HIV+ compared with HIV- men, with adjusted difference of 2.65 g/m2 (95% confidence interval 0.53-4.77, p < .001). Left ventricular end-diastolic index and LAVI did not differ significantly between the two groups. HIV-related factors (nadir CD4 count, clinical AIDS diagnosis, cumulative antiretroviral therapy use, and cumulative protease inhibitor use) were not significantly associated with LVMI, LVEDVI, or LAVI. LVM was significantly higher in HIV+ than HIV- men, which may contribute to the observed increased risk for diastolic heart failure associated with HIV infection. Although HIV infection has been associated with an increased risk for atrial fibrillation, we did not find any difference in LAV by HIV serostatus.

KW - AIDS

KW - cardiomyopathy

KW - diastolic

KW - heart failure

KW - HIV

KW - X-ray computed tomography

UR - http://www.scopus.com/inward/record.url?scp=85070359213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070359213&partnerID=8YFLogxK

U2 - 10.1089/aid.2019.0014

DO - 10.1089/aid.2019.0014

M3 - Article

C2 - 31044604

AN - SCOPUS:85070359213

VL - 35

SP - 755

EP - 761

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 8

ER -